Bioverativ Therapeutics Inc.;Swedish Orphan Biovitrum AB (publ)
发明人:
Dumont, Jennifer,Jain, Nisha,Lethagen, Stefan
申请号：
AU2017368328
公开号：
AU2017368328A1
申请日:
2017.12.01
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
The present disclosure provides methods inducing immune tolerance in a human, comprising administering to the human an effective amount of a composition or a chimeric protein comprising a clotting factor and an Fc region.
